Skip to main content
. Author manuscript; available in PMC: 2013 Feb 1.
Published in final edited form as: Biomaterials. 2011 Nov 26;33(5):1607–1617. doi: 10.1016/j.biomaterials.2011.11.011

Figure 7.

Figure 7

Trans-epidermal water loss (TEWL) values of each day after treatment of spantide II and ketoprofen comprising gel (SP+KP gel) and skin penetrating nanogel comprising ketoprofen (KP-SPN), spantide II (SP-SPN), a combination of spantide II and ketoprofen (SP+KP-SPN) along with a positive control, Topgraf® (tacrolimus ointment 0.1%) for 5 days on the back skin of C57/BL mice. Values represent mean ± SD, n = 6.